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resolution and signal-to-noise ratio, holotomography represents
nowadays one of the best solutions for long term live cell imaging
applications.
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Nanosized cellulose (NC) is a material of natural origin obtained
by an eco-friendly procedure, in the form of fibrils (NCF) or crys-
tallites (CNC). In particular, CNC prepared by carboxylation and
ultrasonic dispersion according to Saito et al. 1, are rod-shaped,
rigid and regular nanostructures with thickness 3-5 nm and 250-
500 nm length2,3. The high surface area together with the strong
hydrogen bonding and cation coordination capacity, favour the
interaction of CNCs with the surrounding species.  Accordingly,
CNCs are easily dispersed in water, while undergo a layer-by-
layer assembly when dried and entangle in soft hydrogels by a
cation-driven process. CNC-derived materials show unique fea-
tures in term of structure and functional properties and are suit-
able for the fabrication of medical and life science devices.
However, the nanotoxicity of CNC as component of biomedical
devices is still an open question. In this presentation we will
report about the fabrication of CNC hydrogels and their incorpo-
ration in nanocomposite materials. The material properties such
as microstructure, mechanical performances, and in vitro toxicity
are also presented.
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Myotonic dystrophy type 1 and 2 (DM1 and DM2) are genetic
disorders caused by CTG and CCTG expanded repeats, respec-
tively. The transcribed expanded RNAs accumulate in nuclear
foci where splicing factors are sequestered, thus causing a gener-
al splicing deregulation in multiple tissues. In both DMs, patho-
logical traits are muscle weakness, dystrophy/atrophy and
myotonia, with disabling effects and possibly premature death.
Currently, no therapy is available for DMs. Different therapeutic
molecules have been successfully tested in experimental models
to target the expanded RNAs; however, most of the delivery or
toxicity problems remain unsolved. Our research aims at design-
ing a novel therapeutic strategy using biocompatible nanoparti-
cles (NPs) to administer drugs or oligonucleotides able to coun-
teract RNA toxicity in DMs, with special reference to skeletal
muscle. Drug-loaded NPs may improve therapeutic efficacy by
protecting the encapsulated molecules from enzymatic degrada-
tion and ensuring their delivery and sustained release inside the
cell. Among the different NPs we tested, poly(lactide-co-glycol-
ide) (PLGA) NPs and hyaluronic acid (HA)-based NPs proved to
be highly biocompatible for cultured murine and human
myoblasts and myotubes1,2. We elucidated the mechanisms of
their uptake, distribution and degradation by fluorescence and
transmission electron microscopy. We also investigated NPs dis-
tribution in explanted mouse skeletal muscles maintained under
fluid dynamic conditions3. Both PLGA and HA NPs proved to
efficiently load pentamidine, one of the promising therapeutic
agents, and preliminary results on cultured myoblasts from DM1
patients demonstrated that pentamidine delivered by PLGA NPs
reduced the pathological accumulation of nuclear foci with lim-
ited cytotoxic effects. 
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During last years, evidence has been provided on the involvement
of obesity in the pathogenesis and aggravation of several life-
threatening diseases. In this view, we set up an innovative proto-
col to induce a nanoparticle-mediated lipolysis in vitro by com-
bining light and electron microscopy, and biochemical approach-
es. Under appropriate administration conditions, 3T3-L1 mouse
adipocytes proved to efficiently and safely internalize superpara-
magnetic iron oxide nanoparticles (SPIONs), which are able to
produce heat when subjected to alternating magnetic field1-3.
Thus, 3T3-L1 adipocytes were submitted to SPIONs-mediated
hyperthermia treatment (SMHT), with the aim of modulating
their lipid content4,5. The treatment resulted in a significant delip-
idation persisting for at least 24 h, in the absence of cell death,
damage or dedifferentiation. Interestingly, some factors normally
linked with lipolysis event or in lipid metabolism6 were not mod-
ulated upon SMHT, suggesting the involvement of a novel/alter-
native mechanism in the lipolysis observed. Notably, the same
SMHT was able to induce delipidation also in primary cultures
of human adipose-derived adult stem cells. The success of this
new approach in vitro opens promising perspectives for the appli-
cation of SMHT in different biomedical fields. Next steps could
be the use of SPIONs in an animal model of obesity, to analyze
the metabolic pathways activated by the SMHT, and the applica-
tion of SMHT in an experimental model of cancer in obese mice
to study the crosstalk between adipose and tumor tissues.
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